Therefore, we hypothesize that by delivering specific miRNA to recipient cells, OM-EV may activate AMPK and downregulate mTOR, thus altering the metabolic state of the cell and leading to the upregulation of the expressions of DSPP, DMP1, and Runx2, and the odontogenic differentiation of DPSCs. This evidence concerns the gene DMP1 and ocular melanoma.